Tedalinab (GRC-10693) 是一种有效的、具有口服活性的、选择性大麻素受体 2 (CB2) 激动剂。Tedalinab 对 CB2 的选择性大 CB1 的 4700 多倍。Tedalinab 具有用于神经性疼痛和骨关节炎的潜力。
货号:ajcx39266
CAS:916591-01-0
分子式:C19H21F2N3O
分子量：345.39
溶解度:DMSO : 100 mg/mL (289.53 mM; ultrasonic and warming and heat to 60°C)
纯度：98%
存储：Store at -20°C
库存：现货

Background:

Tedalinab (GRC-10693) is a potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist. Tedalinab has >4700-fold functional selectivity for CB2 over CB1. Tedalinab has potential for neuropathic pain and osteoarthritis treatment[1].

[1]. Glenmark's molecule for neuropathic pain, osteoarthritis - GRC 10693, successfully completes Phase I trials.

Protocol:

CB2